Abstract

A simple, rapid, accurate and precise spectrophotometric method is proposed for determining metoclopramide – hydrochloride (MCPH) in pure form and in pharmaceutical preparations .The method is based on oxidation - reduction reaction between metoclopramide - hydrochloride and cerium (IV) ion, then the subsequent reaction of cerium (III) and arsenazo III reagent in acidic medium to produce a blue-violet complex which is stable, water-soluble and has a maximum absorption at 654nm with a molar absorptivity of 9.36x104 l.mol-1.cm-1 and Sandell's sensitivity of 0.0038 µg.cm-2. Beer's law is obeyed in concentration range from 1-30 µg metoclopramide - hydrochloride in final volume of 25 ml, (0.04-1.2) ppm with a relative standard deviation (RSD) ( ±1.80% - ±3.98%) and the limit of detection (LOD) is 0.0095 µg/ml and the limit of quantitation (LOQ) is 0.0317 µg/ml . The method is suitable for the determination of metoclopramide - hydrochloride in the presence of other ingredients that are usually present in dosage forms and the recoveries are obtained in the range of 97.6-101.0 % . The proposed method has been applied successfully to the determination of the intended compound in its pharmaceutical preparations ( tablet and injection).

Highlights

  • A simple, rapid, accurate and precise spectrophotometric method is proposed for determining metoclopramide – hydrochloride (MCPH) in pure form and in pharmaceutical preparations .The method is based on oxidation - reduction reaction between metoclopramide - hydrochloride and cerium (IV) ion, the subsequent reaction of cerium (III) and arsenazo III reagent in acidic medium to produce a blue-violet complex which is stable, water-soluble and has a maximum absorption at 654nm with a molar absorptivity of 9.36x104 l.mol-1.cm-1 and Sandell's sensitivity of 0.0038 μg.cm-2

  • The drug was used for the control of sickness due to radiation therapy and chemotherapy, and for the prevention and treatment of postoperative nausea and vomiting (PONV)

  • The intensity of the formed complex has been found to be proportional to the amount of MCPH originally present in solution

Read more

Summary

Introduction

A simple, rapid, accurate and precise spectrophotometric method is proposed for determining metoclopramide – hydrochloride (MCPH) in pure form and in pharmaceutical preparations .The method is based on oxidation - reduction reaction between metoclopramide - hydrochloride and cerium (IV) ion, the subsequent reaction of cerium (III) and arsenazo III reagent in acidic medium to produce a blue-violet complex which is stable, water-soluble and has a maximum absorption at 654nm with a molar absorptivity of 9.36x104 l.mol-1.cm-1 and Sandell's sensitivity of 0.0038 μg.cm-2. Metoclopramide was used as a treatment of nausea and vomiting in association with migraine and severe headache. In this setting, the combination of metoclopramide with an analgesic proved to be very efficacious with a short delay of action. The chromatographic methods are a lot cost, they are consuming of time and limiting of application and the flow-injection chemiluminescent are often typically less sensitive and have their own intrinsic disadvantages such as technical complexity or require an expensive instrumentation (Al-Arfaj, 2004)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call